MERCALIS AND TRIANGLE INSIGHTS GROUP ANNOUNCE SENIOR LEADERSHIP APPOINTMENTS
MERCALIS AND TRIANGLE INSIGHTS GROUP ANNOUNCE SENIOR LEADERSHIP APPOINTMENTS
"The addition of Aileen and Michael further strengthens the Triangle and Mercalis leadership teams," said MORRISVILLE, N.C. and DURHAM, N.C., Aug. 6, 2024 /PRNewswire/ -- Triangle Insights Group (Triangle), a premier strategy consulting firm that advises senior life science leaders in the pharmaceutical, biotechnology, and related industries on questions related to market access, commercial strategy, product launch, and corporate strategy, today announced two appointments that further strengthen the firm's senior leadership team. Triangle, acquired by life sciences commercialization company Mercalis in April 2022, has named both Aileen Nicoletti, PhD and Michael Turner as Partners. Nicoletti and Turner help to expand and strengthen the product strategy and launch excellence capabilities of Triangle.
Triangle Insights Group（Triangle）是一家重要的策略諮詢公司，爲製藥、生物技術和相關行業的高級生命科學領導者提供關於市場準入、商業策略、產品發佈和企業策略等問題的建議。2022年4月被生命科學商業化公司Mercalis收購的Triangle宣佈任命Aileen Nicoletti博士和Michael Turner爲合夥人，進一步增強公司的高級領導團隊的能力並拓展、加強產品戰略和發佈卓越能力。
Nicoletti is a life sciences consultant with over 20 years of experience advising biotech and pharmaceutical clients on portfolio and commercialization strategy. Her focus has involved new product planning, portfolio management, and brand and launch strategy. She is adept at building bridges across functions and telling compelling stories to support key strategic decisions. Her strong operational experience in developing consulting teams, tools, and operations has led to rapid growth of the consulting firms she has led in the past. Nicoletti earned a BS in Chemistry from the College of William and Mary and a PhD in Biochemistry from the University of Michigan.
Nicoletti是一位有着20多年生命科學諮詢經驗的諮詢顧問，爲生物技術和製藥客戶在組合產品規劃、組合管理和品牌發佈策略方面提供諮詢建議。她善於在各個領域之間建立橋樑，並講述有力的故事以支持關鍵戰略決策。她在發展諮詢團隊、工具和運營方面的強大操作經驗，導致了她過去領導的諮詢公司的快速增長。Nicoletti獲得了College of William and Mary的化學學士學位和密歇根大學的生物化學博士學位。
Turner is a seasoned leader and client strategic partner with over 25 years of commercial strategy consulting experience in life sciences. He has served as an advisor to emerging and established biopharmaceutical company commercial leaders in new product planning/go-to-market strategy, commercial and competitive strategy, and portfolio strategy. Throughout his career, he has supported the commercialization of over 75 global launch products across most therapeutic areas and has helped over 20 emerging pharma companies prepare for their first US launches. As part of his launch and commercialization work, he has also worked extensively with companies on their patient and physician services programs. Turner holds a BS in Operations Research and Engineering from Cornell University's College of Engineering and an MBA from the University of Michigan's Ross School of Business.
Turner是一位商業戰略諮詢經驗豐富、有25年以上的生命科學經驗的領導者和客戶戰略合作伙伴。他曾擔任新產品規劃/上市策略、商業和競爭策略以及產品組合策略的新興與成熟生物製藥公司商業領導的顧問。在他的職業生涯中，他支持了全球各個治療領域的75個全球發佈產品的商業化，並幫助超過20個新興製藥公司準備在美國的首次發佈。作爲他的發佈和商業化工作的一部分，他還廣泛地與公司合作開展患者和醫生服務計劃。Turner擁有康奈爾大學工程學院運籌學和工程學學士學位以及密歇根大學羅斯商學院的工商管理碩士學位。
"The addition of Aileen and Michael further strengthens the Triangle and Mercalis leadership teams," said Chris Apolito, Founding Partner of Triangle Insights Group. "For many years, both individuals have demonstrated excellence in their fields and are very highly respected in the world of life sciences consulting. I look forward to the many contributions they will make going forward."
Triangle Insights Group的創始合夥人Chris Apolito表示: "Aileen和Michael的加入進一步增強了Triangle和Mercalis領導團隊的實力。這些人在他們的領域中多年的表現出色，深受生命科學諮詢界的高度讚譽。我期待他們今後會做出的很多貢獻。"
To learn more about Triangle Insights Group, please visit .
要了解更多有關Triangle Insights Group的信息，請訪問網站。
About Triangle Insights Group
關於Triangle Insights Group
Triangle Insights Group by Mercalis is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. The firm's approach combines deep industry knowledge with strong analytical rigor to drive strategic decision-making across client domains. Triangle's expertise encompasses key therapeutic areas (oncology, CNS, cell, and gene therapy) and relevant industry disciplines (pricing and market access, new product planning, and commercial strategy). For more information, visit .
Triangle Insights Group是Mercalis提供的一個重要的策略諮詢公司，爲生命科學行業領袖提供關鍵業務問題的指導。該公司的方法結合了深厚的行業知識和強大的分析嚴謹性，以在客戶領域推動戰略決策制定。Triangle的專業知識包括重要治療領域（腫瘤學、中樞神經系統、電芯和基因療法）和相關工業學科（定價和市場準入、新產品規劃和商業策略）。要了解更多信息，請訪問網站。
About Mercalis
關於Mercalis
Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace to accelerate value and enhance patient lives. Founded in 2000, Mercalis provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina. For more information about Mercalis, please visit .
Mercalis是一個綜合的生命科學商業合作伙伴，提供涵蓋整個醫療保健價值鏈的全面解決方案。該公司與其客戶密切合作，提供端到端的商業能力譜系，無縫靈活地合作。基於行業的卓越專業知識和結果驅動的技術支持，Mercalis提供數據和戰略洞察、患者支撐服務和醫療保健提供者參與工具，以幫助生命科學公司成功地商業化新產品並在複雜的生命科學市場中航行，加速價值並增強患者生命。Mercalis成立於2000年，爲500多家生命科學客戶提供商業化解決方案，併爲數百萬患者提供了訪問和負擔能力支持。公司總部位於北卡羅來納州莫里斯維爾。要了解更多有關Mercalis的信息，請訪問網站。
Contact:
Landy Townsend
VP, Marketing & Communications
Mercalis
[email protected]
聯繫方式：
Landy Townsend
VP，市場和通信
Mercalis
[email protected]
SOURCE Mercalis
來源：Mercalis
譯文內容由第三人軟體翻譯。